FilingSEC EDGAR8-K
Invivyd Announces Positive Phase 3 Results for VYD2311
· SEC accepted
Stagephase_3
Filing content
Invivyd announced positive Phase 3 results for VYD2311, demonstrating superior safety compared to COVID-19 vaccines, and plans to submit a BLA to the FDA.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…